Battle gets fierce over generic Ultracet market
Published: 2010-09-01 06:59:00
Updated: 2010-09-01 06:59:00
Korean drug manufacturers have waged fiercer campaigns to raise their generic Ultracet (tramadol + acetaminophen) market share amid forecasts that their revenues will fall gradually due to stronger competition from a number of new comers.
Major drug makers, such as Samjin Pharm, Dong-A Pharm, ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
